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Introduction
There is some controversy as to who (and when) 
exactly performed the first laparoscopic splenec-
tomy (LS) [1]. The year 1991 and the author Carroll 
et al. [2] or (more likely) Delaitre and Maignien [3, 4] are 
most frequently mentioned. Anyway, this procedure 
has been available for more than a quarter of a centu-
ry and has replaced in most centers traditional, open 
splenectomy (OP). Even though many authors share 
the opinion about the “standardized approach” there 
are some important differences regarding the surgical 
technique. Some reports concentrate mostly on the 
access to the peritoneal cavity, discussing differenc-
es between 4-port laparoscopy, SILS, Hand-assisted 
laparoscopic surgery (HALS) etc. However, regarding 
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A b s t r a c t
Introduction: Throughout our 20 years of experience, we have used several different techniques for laparoscopic 
splenectomy (LS). However, two methods have been used most frequently: “vessels first” and “hilar transection”.
Aim: To evaluate the outcomes of LS performed with these two different approaches.
Material and methods: It was an observational study based on retrospective analysis of consecutive patients under-
going LS in a tertiary referral surgical center in the period 1998–2017. We excluded patients with splenic trauma, 
initially submitted to open surgery, stapled transection of splenic hilum, partial resections of the spleen and other 
spleen-preserving procedures. Patients were divided into two groups: group 1 (“vessels first”) with 188 patients, and 
group 2 (“hilar transection”) with 287 patients.
Results: Mean operative time was shorter (p < 0.001) and blood loss was lower (p < 0.001) in group 2. The need for 
blood transfusions and the conversion rate were higher in group 1 (p = 0.044 and p = 0.003 respectively). There was 
no difference in intraoperative adverse events (p = 0.179). Overall postoperative morbidity did not differ between 
groups (p = 0.081) and we noted mortality of 0.21% (1 patient of group 2). The morbidity rate associated with acci-
dental injury of the pancreatic parenchyma was significantly higher in group 1 (p = 0.028). Median length of hospital 
stay was 4 days (range: 1–99) and did not differ between groups (p = 0.175). 
Conclusions: The “vessels first” technique is associated with longer operative time, higher blood loss and increased 
risk of conversion. “Hilar transection” is associated with lower incidence of local complications related most likely 
to accidental injury of the pancreatic tail. In the case of a large caliber of splenic vessels the “vessels first” approach 
remains the technique of choice.
Key words: laparoscopy, spleen, splenectomy, vessels first, hilar transection, morbidity, mortality.
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postoperative course this seems to be of lesser im-
portance than the technique of dissection and control 
of splenic vascular supply. Throughout the 20 years 
of our experience, with more than 500 laparoscopic 
operations of the spleen, we have attempted to use 
several different techniques. However, two methods, 
differing in approach to the splenic vessels, referred 
to as “vessels first” and “hilar transection”, have been 
used most frequently. 
Aim
The aim of the study was to evaluate the out-
comes of LS performed with two different approach-
es: “vessels first” and “hilar transection”.
Material and methods
Design
This observational study design was based on 
retrospective analysis of prospectively collected data 
in all consecutive patients undergoing laparoscopic 
operations of the spleen (total splenectomy as well 
as spleen-sparing procedures) in a  tertiary referral 
university surgical center in 1998–2017. Inclusion 
criteria were: elective total splenectomy performed 
for hematological disorders, pure laparoscopic or 
single incision approach, “vessels first” or “hilar tran-
section” technique for control of the vascular supply. 
We excluded patients with splenic trauma, initially 
submitted to open surgery, stapled transection of 
the splenic hilum, partial resections of the spleen 
and other spleen-preserving procedures. Patients 
were divided by operative technique used during the 
operation and analyzed in two groups: group 1 (“ves-
sels first”), and group 2 (“hilar transection”).
Outcomes
The primary outcomes were related to the as-
sessment of the course of the procedure and includ-
ed operative time, conversion rate, intraoperative 
blood loss and intraoperative adverse events/com-
plications. Operative time was measured from skin 
incision to closure. The intraoperative blood loss was 
measured from the amount of blood aspirated in the 
suction machine. Intraoperative adverse events/
complications were defined as any iatrogenic harm-
ful event occurring during the operation, which had 
not derived from the standard technique. Intraoper-
ative blood loss equal to or greater than 500 ml was 
considered to be a  hemorrhage and was included 
as an intraoperative complication, because losing 
less than one unit of blood (≈500 ml) usually does 
not negatively affect the condition of the patient 
and does not lead to hypovolemia and hemorrhagic 
shock [5, 6]. Indications for transfusion were: hemor-
rhagic shock, hemoglobin ≤ 6 g% or 6–8 g% in case 
of evidence for limited compensation and risk fac-
tors (e.g. coronary heart disease, systolic heart fail-
ure, insufficient cerebral vascular flow) or presence 
of the following symptoms: tachycardia, hypoten-
sion, acute coronary ischemia in ECG, acidosis [7].
The secondary outcomes included parameters 
of the postoperative course: 30-day postoperative 
morbidity (graded with Clavien-Dindo classifica-
tion [8]), mortality, reoperations and length of stay. 
W paid special attention to complications that might 
have resulted directly from the operative technique, 
i.e. related to potential injury of the pancreatic tail. 
We defined reoperations as a subsequent operation 
performed due to a postoperative complication after 
LS. The length of stay (LOS) was measured from the 
admission day until discharge.
Operative technique
In our department the primary choice of the op-
erative access to the peritoneal cavity during LS is 
a  laparoscopic 4-port technique. During the study 
period seven patients were operated on through 
a  single incision, but after a  feasibility study this 
technique was abandoned [9, 10]. Hand-assisted 
laparoscopic surgery was used only in 5 cases as 
an alternative to full conversion, but never elective-
ly. Regardless of the access to the peritoneal cavity 
the course of LS was standardized. Patients were 
operated on in the right lateral decubitus position. 
At the beginning of all operations transection of the 
gastro-splenic ligament and short gastric vessels 
with various energy devices was performed. This 
was followed by extensive lateral mobilization of the 
spleen. There were however two different techniques 
of control of splenic vessels. At the beginning of our 
experience we used in all cases the technique re-
ferred to as “vessels first”, described elsewhere [11, 
12]. In this technique the main trunks of the splenic 
artery and vein were identified at the level of the 
pancreatic body/tail, isolated, clipped and transect-
ed. Than the entire splenic hilum including branches 
of all vessels, perivascular fat and lymphatic tissue 
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was dissected away in one block from the pancreatic 
tail and removed together with the spleen (Photo 1). 
This approach does not require the use of a stapler, 
and because of its cost-effectiveness it was initially 
adopted for standard use during all LS. However, this 
technique has been mostly abandoned nowadays 
and is used only for patients with a particularly large 
caliber of splenic vessels, i.e. portal hypertension or 
splenomegaly.
Nowadays a different technique, referred to as 
“hilar transection”, has been introduced. In this ap-
proach the main, nominate splenic vessels are not 
isolated. The entire splenic hilum is transected, as 
close as possible to the splenic parenchyma, with 
a new generation of energy devices – Ligasure (Co-
vidien) and more recently Thunderbeat (Olympus) 
(Photo 2). Both allow for safe closure of the vascu-
lar branches in the splenic hilum without use of sta-
ples. Occasionally some clips are applied on larger 
branches of vessels in the hilum, and the decision 
about their use belongs to the operating surgeon. 
Ethics
The study was conducted according to the Report 
of the ISPOR Task Force on Retrospective Databas-
es [13]. To ensure the quality of published studies 
that use health-related retrospective databases, 
a  checklist that focuses on issues that are unique 
to database studies or are particularly problematic 
in database research was developed. Checklist ques-
tions cover a  wide range of issues, including rele-
vance, reliability and validity, data linkages, eligibili-
ty determination, research design, treatment effects, 
sample selection, censoring, variable definitions, re-
source valuation, statistical analysis, generalizabili-
ty, and data interpretation. All procedures followed 
the ethical standards of the responsible committee 
on human experimentation (institutional and na-
tional) and the 2013, Fortaleza revision of the 1975 
Declaration of Helsinki. The study was approved by 
an independent ethics committee of the Jagiello-
nian University, Krakow, Poland (approval number 
1072/6120/160/2017). Informed consent for the 
surgical treatment was obtained from all patients 
before the procedure.
Statistical analysis
All data were analyzed with StatSoft Statistica 
v.12.5 (StatSoft Inc, Tulsa, Oklahoma, USA). The re-
sults are presented as mean ± standard deviation 
(SD), median and interquartile range (IQR), when 
appropriate. The study of categorical variables used 
Pearson’s c2 test, or c2 with Yates’ correction, when 
appropriate. The Shapiro-Wilk test was used to 
check for normal distribution of data. Quantitative 
data were analyzed with Student’s t-test (for nor-
mally distributed data) and the Mann-Whitney test 
(for non-normally distributed data). Results were 
considered statistically significant when the p-value 
was found to be less than 0.05.
Photo 1. Laparoscopic splenectomy performed 
according to the “vessels first” approach. The 
entire splenic hilum is dissected together with 
the spleen from the pancreatic tail
S – spleen, H – splenic hilum, P – pancreas.
Photo 2. Laparoscopic splenectomy performed 
according to the “hilar transection” approach. 
The splenic hilum is transected at the level of 
the splenic parenchyma with an energy device
S – spleen, H – splenic hilum, P – pancreas.
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Material
In the period 1998–2017, we performed 545 lap-
aroscopic operations of the spleen. The most com-
mon procedure was LS, which was performed in 
487 patients. Seventy-two patients were excluded 
from the study group. The flow chart (Figure 1) pres-
ents the design of the study group in detail and rea-
sons for exclusion. There were 188 patients included 
in group 1 (“vessels first”), and 287 in Group 2 (“hilar 
transection”). 
The study group consisted of 303 (63.79%) wom-
en and 172 (36.21%) men. The median age was 
45 (15–84) years. The indications for splenectomy 
are presented in Table I. The analyzed groups did 
not differ in demographics parameters. The details 
of data in both subgroups are presented in Table II. 
Results
The median operative time in the entire group 
was 100 (75–130) min. The median blood loss in the 
whole study was 50 ml (min.–max.: 0–1500; IQR: 
20–150). A total of 34 patients required blood trans-
fusion of 1–9 units of packed red blood cells. The 
Operations of the spleen 
(n = 545) 
Splenectomy 
(n = 487) 
Group I 
“vessels first” 
(n = 188) 
Group II 
“hilar transection” 
(n = 287)
Different technique  
of splenectomy (n = 12) 
Excluded: 
•  Spleen preserving proce-
dures (n = 58) 
–  unroofing of the cyst  
(n = 25) 
–  partial splenectomy  
(n = 17) 
–  resection of the splenic 
artery aneurysm  
(n = 12)
–  hemostasis (n = 3) 
–  drainage of abscess  
(n = 1)
Figure 1. Flowchart of patients through the study
Table I. Indications for LS
Indication Total Group 1 Group 2
N (%) Size of the spleen, 
median (IQR) [cm]
N (%) Size of the spleen, 
median (IQR) [cm]
N (%) Size of the spleen, 
median (IQR) [cm]
ITP 254 (53.47) 11.5 (10–13) 99 (52.66) 11 (10–13) 155 (54.01) 12 (10–13)
Lymphoma 101 (21.26) 19 (17–23) 43 (22.88) 20 (18–27) 58 (20.21) 17 (15.5–20)
Spherocytosis 32 (6.74) 17.5 (15–20) 15 (7.97) 18 (15–22) 17 (5.93) 17 (16–20)
Autoimmune anemia 23 (4.84) 15 (14–17) 9 (4.79) 17 (15–17) 14 (4.88) 14 (12.5–17)
Tumor 20 (4.21) 14 (11–15.5) 1 (0.54) 17 (17–17) 19 (6.63) 14 (10–15)
Splenomegaly 22 (4.63) 18 (16–20) 12 (6.38) 20 (18–30) 10 (3.48) 16.5 (15–18)
Leukemia 9 (1.89) 18 (17–22) 5 (2.66) 20 (17–25) 4 (1.39) 17.5 (14.75–20)
Other: 14 (2.95) 15 (12–20) 4 (2.13) 25 (20–35) 10 (3.48) 14.5 (11–15.5)
Sarcoidosis 4 0 4
Splenic artery 
aneurysm
3 1 2
Osteomyelofibrosis 2 2 0
Splenic cyst 4 0 4
Gaucher disease 1 1 0
Total 475 (100) 14 (11–17) 188 15 (11–20) 287 13 (11–17)
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overall conversion rate was 3.16%, and the intraop-
erative complication rate was 5.68%. Analysis of the 
parameters related to the course of the procedure 
included in the primary outcomes are presented in 
Table III. 
Table II. Patients’ characteristics
Parameter Group 1 Group 2 P-value
Number of patients 188 287 –
Age [years]: 0.0011
Median 40 50
IQR 23–55.5 31–60
Range 15–84 17–84
Female, n (%) 124 (65.96) 179 (62.37) 0.4262
Male, n (%) 64 (34.04) 108 (37.63)
ASA 1, n (%) 43 (22.87) 68 (23.69) 0.8042
ASA 2, n (%) 58 (30.85) 81 (28.22)
ASA 3, n (%) 49 (26.06) 85 (29.62)
ASA 4, n (%) 38 (20.21) 53 (18.47)
Size of the spleen [cm]: < 0.0011
Median 15 13
IQR 11–20 11–17
Range 9–37 4–30
1Mann-Whitney test, 2Pearson’s c2 test.
Table III. Analysis of intraoperative parameters 
in subgroups
Parameter Group 1 Group 2 P-value
Operative time [min]: < 0.0011
Median 135 90
IQR 100–160 70–120
Range 50–240 25–280
Intraoperative blood loss [ml]: < 0.0011
Median 100 50
IQR 50–400 20–100
Range 10–1200 0–1500
Need for blood 
transfusion, n (%)
19 (10.11) 15 (5.23) 0.0442
Conversion, n (%) 12 (6.38) 3 (1.05) 0.0033
Intraoperative com-
plications, n (%)
14 (7.45) 13 (4.53) 0.1792
1Mann-Whitney test, 2Pearson’s c2 test, 3c2 test with Yates’ correction.
Table IV. Intraoperative adverse events and rea-
sons for conversions
Intraoperative adverse events Group 1 Group 2
Accidental injury of intra-abdominal organ:
Stomach 3 (1.59%) 1 (0.35%)
Splenic flexure 0 2 (0.69%)
Diaphragm (sutured without 
chest tube)
2 (1.06%) 0
Small bowel 0 1 (0.35%)
Pancreatic tail 0 1 (0.35%)
Bladder (Pfannenstiel incision) 1 (0.53%) 0
Massive bleeding:
Managed laparoscopically 2 (1.06%) 4 (1.39%)
Requiring conversion 2 (1.06%) 3 (1.05%)
Rupture of the retrieval bag 4 (2.13%) 1 (0.35%)
Total 14 (6.38%) 13 (4.53%)
Reasons for conversions Group 1 Group 2
Bleeding 2 (1.06%) 3 (1.05%)
Technical problems 4 (2.13%) 0
Infiltration of surrounding 
structures
4 (2.13%) 0
Spleen’s friability 1 (0.53%) 0
Size of the spleen 1 (0.53%) 0
Total 12 (7.45%) 3 (1.05%)
The average operative time in “hilar transection” 
group was shorter (135 min vs. 90 min respective-
ly), and the difference was statistically significant 
(p < 0.001). The median blood loss was also sig-
nificantly lower in the same group (p < 0.001). The 
conversion rate was higher in group 1 (6.38% vs. 
1.05%). The difference was statistically significant 
(p = 0.003). There was no difference in the rate of 
intraoperative adverse events between study groups 
(p = 0.179). Most intraoperative adverse events were 
accidental injuries of various organs, which were re-
paired laparoscopically. The second most common 
group was massive bleeding, which required conver-
sion in half of the cases. The number and types of 
intraoperative complications along with reasons for 
conversions in both study groups are listed in Table IV. 
Secondary outcomes reflecting safety of the pro-
cedure are listed in Table V. Overall postoperative mor-
bidity was 8.42% (40 patients) and we noted mortal-
ity of 0.21% (1 patient). This patient was operated on 
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for massive splenomegaly caused by lymphoma. He 
was reoperated on classically 1 h after LS because of 
massive bleeding and again 2 h later for rebleeding 
with the need for CPR during surgery and eventually 
died in the intensive care unit (ICU). 
There were more postoperative complications in 
the “vessels first” group (11.17% vs. 6.62%), but the 
difference was not significant (p = 0.081). Howev-
er, the morbidity rate of complications attributed to 
accidental injury of the pancreatic parenchyma was 
significantly higher in group 1 (abscess or fluid col-
lection in the splenic bed, pancreatitis, pancreatic 
fistula) (5.32% vs. 1.39%; p = 0.028). Classification 
of perioperative (≤ 30 days) complications accord-
ing to the Clavien-Dindo classification is present-
ed in Table VI. Median length of hospital stay was 
4 days (range: 1–99) and did not differ between 
study groups (p = 0.175). 
Table V. Analysis of secondary outcomes in sub-
groups
Outcome Group 1 Group 2 P-value
Postoperative 
morbidity
21 (11.17%) 19 (6.62%) 0.0811
Complications 
related to injury  
of the pancreas
10 (5.32%) 4 (1.39%) 0.0282
Reoperation 8 (4.25%) 11 (3.83%) 0.6352
Mortality 0 1 –
Length of stay [days]: 0.1753
Median 4 5
IQR 3–6 4–6
Range 3–99 2–36
1Pearson’s c2 test, 2c2 test with Yates’ correction, 3Mann-Whitney test.
Table VI. Perioperative (≤ 30 days) complications according to Clavien-Dindo grading
C-D Complications Group 1 Group 2
5 Massive intraoperative blood loss. Reoperation for recurrent hemorrhage (patient death) 0 1 (0.35%)
4b Pancreatic fistula with abscess and secondary perforation of splenic flexure. Multiple 
reoperations. Cardiorespiratory failure (ICU stay)
1 (0.53%) 0
3b Postoperative bleeding (relaparoscopy) 2 (1.06%) 4 (1.39%)
Subphrenic abscess (reoperation) 3 (1.59%) 2 (0.69%)
Acute pancreatitis (reoperation) 1 (0.53%) 1 (0.35%)
Perforation of the fundus of the stomach probably due to thermal injury (reoperation on 
8th postoperative day)
0 1 (0.35%)
Subphrenic hematoma (operative drainage) 0 1 (0.35%)
Thrombosis of superior mesenteric artery (revascularization) 0 1 (0.35%)
Pancreatic fistula 1 (0.53%) 0
3a Subphrenic abscess (percutaneous drainage) 1 (0.53%) 1 (0.35%)
Port-site bleeding (suture ligation under local anesthesia) 0 1 (0.35%)
Pelvic hematoma (percutaneous drainage) 1 (0.53%) 0
Pneumothorax (chest tube) 0 1 (0.35%)
2 Fever of unknown origin 4 (2.13%) 3 (1.05%)
Pulmonary infection 1 (0.53%) 1 (0.35%)
Urinary tract infection 1 (0.53%) 0
Superior mesenteric vein thrombosis 1 (0.53%) 0
Subphrenic hematoma 0 1 (0.35%)
1 Subphrenic fluid collection 3 (1.59%) 0
Pneumothorax (spontaneous resolution) 1 (0.53%) 0
Total 21 (11.17%) 19 (6.62%)
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Discussion
In this study based on the analysis of outcomes 
of 475 laparoscopic splenectomies we were able to 
document that there are important differences in 
the postoperative outcome related to the technique 
of dissection and control of splenic vessels. The ap-
proach referred to as “hilar transection” in which 
vessels are transected practically at the level of the 
splenic parenchyma was associated with lower over-
all morbidity and significantly lower rates of local 
complications related most likely to accidental injury 
of the pancreatic tail. This method is, however, of 
limited use in patients with a large caliber of splenic 
vessels in portal hypertension or massive spleno-
megaly due to different causes, where the “vessels 
first” approach remains the technique of choice.
Currently there is no doubt that laparoscopy is 
the preferred approach for splenectomy. The ben-
efits of this operation have been documented in 
many studies. The results are surprisingly good, and 
LS has become the standard approach for most elec-
tive operations. The numerous advantages of lapa-
roscopy such as early recovery, lower postoperative 
pain, reduced surgical trauma and blood loss, low-
er complication rate and mortality, and better cos-
metic effect have made it the method of choice in 
most centers [14–19]. Initially it was used only for 
cases expected to be easy and hassle-free, mainly 
idiopathic thrombocytopenic purpura (ITP) and he-
molytic anemias with nonenlarged spleens [20, 21]. 
Later, growing experience allowed for safe use of 
this method even in difficult cases including massive 
splenomegaly [22–25]. Laparoscopic splenectomy 
may also be safely performed in patients at high risk 
of complications related to clotting disorders includ-
ing end-stage thrombocytopenia [26, 27].
After more than a quarter of a century it is be-
lieved that the technique of LS is more or less stan-
dardized [28–30]. However, most reports do not 
concentrate on differences in the surgical technique, 
which in our opinion are crucial. There are publica-
tions that focus mostly on surgical access to the 
peritoneal cavity rather than the technique of dis-
section of the splenic hilum and control of the vas-
cular pedicle of the spleen [9, 10, 31, 32]. In the tech-
nique referred to as “vessels first” the entire splenic 
hilum including branches of all vessels, perivascular 
fat and lymphatic tissue was dissected away in one 
block from the pancreatic tail and removed together 
with the spleen. The main benefit of this approach 
was cost-effectiveness as it did not require the use 
of a vascular stapler – very popular in those times, 
but expensive. Even though economic issues are not 
analyzed in this paper, we believe that the “vessels 
first” technique was much less expensive and this 
aspect was most important for us in those times. We 
could document its feasibility and safety [11, 12]. 
With growing experience we found that it is related 
to relatively high incidence of various local compli-
cations including abscesses and fluid collections in 
the splenic bed, pancreatitis and pancreatic fistulas. 
We found evidence supporting this observation in 
the present study. The rate of those complications 
was almost twice as high in this group. This could 
be the result of dissection very close to the pan-
creatic parenchyma, which may cause direct injury, 
burns and ischemia of the pancreatic tail, leading 
to the abovementioned complications. Introduction 
of new generations of energy devices that allow for 
safe closure of relatively large vessels without clips 
resulted in a change in the operative approach. The 
dissection plane could be transferred from the pan-
creatic parenchyma to the splenic parenchyma. This 
allowed for protection of the pancreatic tail and re-
sulted in a decrease in the risk of its injury. The re-
duction of local complications was documented in 
our study. There are more benefits of this technique. 
It is less time-consuming and is associated with 
lower blood loss and a  lower conversion rate. The 
technique itself has some limitations. The caliber 
of vessels safely closed by energy devices is in the 
range 5–7 mm [33–35]. Usually in cases of non-en-
larged spleens this is enough. However, sometimes, 
even in those cases, the diameter of branches in the 
splenic hilum, close to the splenic parenchyma, may 
be larger. There are two possible approaches to this 
situation. If those large-caliber vessels can be iden-
tified in the splenic hilum they can be individually 
clipped before transection. However, this technique 
may be difficult and time-consuming when numer-
ous dilated branches are found, and this makes the 
procedure rather troublesome. We use a  different 
method more frequently in cases when we expect 
to find larger vessels. In those patients the “vessels 
first” approach is still the primary technique, as it 
requires identification and isolation of only two 
vessels: the main trunks of the splenic artery and 
vein. Nowadays the “vessels first” technique is used 
mostly for difficult cases of large spleens or portal 
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hypertension, which can explain, at least partially, 
the higher conversion rate in this group.
Our study has certain limitations typical for a sin-
gle-center retrospective analysis. There is a potential 
bias regarding the use of postoperative drainage. At 
the beginning we routinely introduced at least one 
drain after each splenectomy. Later we stopped this 
practice, limiting the use of drains to complicated 
cases, for example involving injuries of the pancre-
atic tail [36]. The drains are known to be directly 
related to the occurrence of surgical site infections, 
and the difference in the rate of those complication 
is one of the most important results of the current 
study. Unfortunately, there is a lack of reliable data 
concerning recent use of drains, and we could not 
include this parameter in our analysis. Another lim-
itation is the fact that in this analysis we did not 
include potential postoperative complications that 
might have occurred later than 30 days after dis-
charge. This could certainly influence the overall 
complication rate. 
Conclusions
Postoperative outcome after LS is related to the 
technique of dissection and control of the splen-
ic vascular pedicle. The “vessels first” technique 
is associated with longer operative time, higher 
blood loss and increased risk of conversion. The 
approach referred to as “hilar transection” is asso-
ciated with lower incidence of local complications 
related most likely to accidental injury of the pan-
creatic tail. All those data favor the latter method, 
although in the case of a  large caliber of splenic 
vessels the “vessels first” approach remains the 
technique of choice.
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